It has been suggested this effect of lithium action occurs via the inhibition of GSK-3beta, and this possibility has been supported by the studies of Croft et al. [84], who reported that a different inhibitor of GSK-3beta was also able to modify tau abnormalities in brain slices from 3XTg-AD mice. Here, GSK3B is linked to Alzheimer disease.